ACDPP is a specific antagonist of metabotropic glutamate receptor 5 (mGluR5) that partially blocks the DHPG-induced increase of fragile X mental retardation protein (FMRP), ACDPP is used as a pharmacological tool in neuroscience research to study group I mGluR signaling, synaptic plasticity, and molecular mechanisms underlying fragile X syndrome.
Molecular Weight:
292.72
CAS Number:
[37804-11-8]
Formula:
C12H13ClN6O
Target:
GluR
T22543
T22543
* VAT and and shipping costs not included. Errors and price changes excepted
